Regeneron Pharmaceuticals, Inc.
Status: Publicly traded
Direct answer
Regeneron Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker REGN.
Regeneron Pharmaceuticals, Inc. is a global biopharmaceutical enterprise focused on discovering, inventing, developing, manufacturing, and bringing to market medical treatments for a wide array of illnesses. Its therapeutic portfolio includes EYLEA, an injection used to treat various ophthalmic conditions such as wet age-related macular degeneration, diabetic macular edema, myopic choroidal neovascularization,...
Can you invest in Regeneron Pharmaceuticals, Inc.?
Yes. Regeneron Pharmaceuticals, Inc. trades publicly on NASDAQ as REGN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Regeneron Pharmaceuticals, Inc.
Detailed equity research is provided by MarketSnap.